Markets · Asia · KSE

207940.KS Samsung Biologics

₩1,219,000 -4.54%

Asia · Health Care

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

-4.54%

YTD

-21.80%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

-0.02

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 8, 2026 · EOD, no live order book

Open

₩1,273,000

₩1,219,000

VWAP (n/a)

—

Day high

₩1,274,000

Day low

₩1,218,000

Volume

82K

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion

Yahoo Finance · Aug 27

Samsung Biologics Reports Second Quarter 2026 Financial Results

Yahoo Finance · Jul 22

Samsung Biologics: geographic diversification is a sound business decision

Yahoo Finance · Jul 22

Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal

Yahoo Finance · Jul 20

Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth

Yahoo Finance · Jun 30

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

Yahoo Finance · Mar 31

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell 207940.KS. Try it in the Lab to size a position and see the risk.